Risk of a second germ cell cancer after treatment of a primary germ cell cancer in 2201 Norwegian male patients

European Journal of Cancer Part A

Volumn 33, Issue 2, 1997, Pages 244-252

  Wanderås, E Hoff ^a,b   Fossa S D ^a   Tretli, S ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b CANCER REGISTRY OF NORWAY   (Norway)

Author keywords

Cumulative risk; Germ cell neoplasms; Non seminoma; Relative risk; Second germ cell cancer; Seminoma; Testicular neoplasms

Indexed keywords

ADULT; ARTICLE; CANCER RISK; GERM CELL TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; NON SEMINOMATOUS GERMINOMA; NORWAY; PRIORITY JOURNAL; SECOND CANCER; SEMINOMA;

ADULT; AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RISK FACTORS; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 0343118854     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00459-5     Document Type: Article

References (33)

1. In Waterhouse J, Muir C, Correa P, Powell J, eds. Cancer Incidence in Five Continents. IARC Scientific Publications no. 15, Lyon 1976, 3, 512-513.
2. In Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J, eds. Cancer Incidence in Five Continents. Comparability and Quality of Data. IARC Scientific Publications no. 120, Lyon 1992, 6, 972-973.
3. Engeland A, Haldorsen T, Tretli S, et al. Prediction of cancer incidence in the Nordic countries up to the years 2000 and 2010. A collaborative study of the five Nordic Cancer Registries. APMIS, Copenhagen 1993, 101, 67-69.
4. Hay JH, Duncan W, Kerr GR. Subsequent malignancies in patients irradiated for testicular tumours. Br J Radiol 1984, 57, 597-602.
5. Kleinerman RA, Liebermann JV, Li FP. Second cancer following cancer of the male genital system in Connecticut, 1935-82. Natl Cancer Inst Monogr 1985, 68, 139-147.
6. Østerlind A, Berthelsen JG, Abildgaard N, et al. Risk of bilateral testicular germ cell cancer in Denmark: 1960-1984. J Natl Cancer Inst 1991, 83, 1391-1395.
7. Van Leeuwen FE, Stiggelbout AM, van der Belt Dusebout AW, et al. Second cancer risk following testicular cancer: a follow-up study of 1,909 patients [see comments]. J Clin Oncol 1993, 11, 415-424.
8. Wanderås EH, Fosså SD, Tretli S. Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients. Eur J Cancer 1997, 33, 253-262.
9. Peckham MJ, Barret A, McElwain TJ, Hendry WF. Combined management of malignant teratoma of the testis. Lancet 1979, 11, 267-270.
10. Fosså SD, Aass N, Kaalhus O. Radiotherapy for testicular seminoma stage I: treatment results and long-term post-irradiation morbidity in 365 patients. Int J Radiat Oncol Biol Phys 1989, 16, 383-388.
11. Klepp O, Klepp R, Hslash c signst H, Asbjslash c signrnsen G, Talle K, Stenwig AE. Combination chemotherapy of germ cell tumors of the testis with vincristine, adriamycin, cyclophosphamide, actinomycin D and medroxyprogesterone acetate. Cancer 1977, 40, 638-646.
12. Klepp O, Fosså SD, Ous S, et al. Multi-modality treatment of advanced malignant germ cell tumours in males I. Experience with cis-platinum-based combination chemotherapy. Scand J Urol Nephrol 1984, 18, 13-19.
13. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958, 53, 457-481.
14. Fordham MV, Mason MD, Blackmore C, Hendry WF, Horwich A. Management of the contralateral testis in patients with testicular germ cell cancer. Br J Urol 1990, 65, 290-293.
15. Bokemeyer C, Schmoll HJ, Schoffski P, Harstrick A, Bading M, Poliwoda H. Bilateral testicular tumours: prevalence and clinical implications. Eur J Cancer 1993, 29A, 874-876.
16. Dieckmann KP, Loy V, Buttner P. Prevalence of bilateral testicular germ cell tumours and early detection based on contralateral testicular intra-epithelial neoplasia. Br J Urol 1993, 71, 340-345.
17. Colls BM, Harvey VJ, Skelton L, Thompson PI, Frampton CM. Bilateral germ cell testicular tumors in New Zealand: experience in Auckland and Christchurch 1978-1994. J Clin Oncol 1996, 14, 2061-2065.
18. Mumperow E, Lauke H, Holstein AF, Hartmann M. Further practical experiences in the recognition and management of carcinoma in situ of the testis. Urol Int 1992, 48, 162-166.
19. von der Maase H, Rørth M, Walbom-Jørgensen S, et al. Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. Br Med J Clin Res Ed 1986, 293, 1398-1401.
20. Loy V, Dieckmann KP. Prevalence of contralateral testicular intraepithelial neoplasia (carcinoma in situ) in patients with testicular germ cell tumour. Results of the German multicentre study. Eur Urol 1993, 23, 120-122.
21. Skakkebaek NE, Berthelsen JG, Müller J. Carcinoma-in-situ of the undescended testis. Urol Clin North Am 1982, 3, 377-385.
22. Giwercman A, Bruun E, Frimodt-Møller C, Skakkebaek NE. Prevalence of carcinoma in situ and other histopathological abnormalities in testes of men with a history of cryptorchidism. J Urol 1989, 142, 998-1001.
23. Dieckmann KP, Kaup F, Loy V. False-negative biopsy for testicular intraepithelial neoplasia. J Cancer Res Clin Oncol 1992, 119, 1-4.
24. Hoeltl W, Gabriel C, Marberger M. Asynchronous bilateral testicular tumour without previous carcinoma in situ [letter]. Eur J Cancer 1991, 27, 110.
25. Bannwart F, Maurer R, Hedinger C. Carcinoma in situ of the testis [letter; comment]. Histopathology 1991, 18, 189-190.
26. Loy V, Wigand I, Dieckmann KP. Incidence and distribution of carcinoma in situ in testes removed for germ cell tumour: possible inadequacy of random testicular biopsy in detecting the condition [see comments]. Histopathology 1990, 16, 198-200.
27. Fosså SD, Ous S, Åbyholm T, Norman N, Loeb M. Post-treatment fertility in patients with testicular cancer. II. Influence of cis-platin-based combination chemotherapy and of retroperitoneal surgery on hormone and sperm cell production. Br J Urol 1985, 57, 210-214.
28. Fosså SD, Åbyholm T, Normann N, Jetne V. Post-treatment fertility in patients with testicular cancer. III. Influence of radiotherapy in seminoma patients. Br J Urol 1986, 58, 315-319.
29. Daugaard G, Rørth M, von der Maase H, Skakkebaek NE. Management of extragonadal germ-cell tumors and the significance of bilateral testicular biopsies. Ann Oncol 1992, 3, 283-289.
30. Gradishar WJ, Schilsky RL. Effects of cancer treatment on the reproductive system. Crit Rev Oncol Hematol 1988, 8, 153-171.
31. von der Maase H, Meinecke B, Skakkebaek NE. Residual carcinoma-in-situ of contralateral testis after chemotherapy [letter]. Lancet 1988, 1, 477-478.
32. Fosså SD, Aass N. Cisplatin-based chemotherapy does not eliminate the risk of a second testicular cancer. Br J Urol 1989, 63, 531-534.
33. Gerl A, Clemm C, Kohl F, Wilmanns W. Testicular tumor after cisplatin-based chemotherapy for germ cell malignancy. Eur Urol 1994, 25, 216-219.